Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41.

A triterpene derived from betulinic acid (RPR103611) blocks human immunodeficiency virus type 1 (HIV-1) infection and fusion of CD4+ cells with cells expressing HIV-1 envelope proteins (gp120 and gp41), suggesting an effect on virus entry. This compound did not block infection by a subtype D HIV-1 s...

Full beskrivning

Bibliografiska uppgifter

I publikationen:	J Virol
Huvudupphov:	Labrosse, B, Pleskoff, O, Sol, N, Jones, C, Hénin, Y, Alizon, M
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	American Society for Microbiology (ASM) 1997
Ämnen:	Research Article
Länkar:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192280/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9343174/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.71.11.8230-8236.1997
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!